231 related articles for article (PubMed ID: 35902629)
21. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
Sukhram SD; Yilmaz G; Gu J
Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
[TBL] [Abstract][Full Text] [Related]
23. Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depression.
Edem EE; Anyanwu CC; Nebo KE; Akinluyi ET; Fafure AA; Ishola AO; Enye LA
Psychopharmacology (Berl); 2022 Jan; 239(1):185-200. PubMed ID: 34792632
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Mechanisms of Ketamine.
Mihaljević S; Pavlović M; Reiner K; Ćaćić M
Psychiatr Danub; 2020; 32(3-4):325-333. PubMed ID: 33370729
[TBL] [Abstract][Full Text] [Related]
25. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K
Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852
[TBL] [Abstract][Full Text] [Related]
26. Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networks.
Wu Z; Cai Z; Shi H; Huang X; Cai M; Yuan K; Huang P; Shi G; Yan T; Li Z
Aging (Albany NY); 2022 Apr; 14(8):3569-3596. PubMed ID: 35468096
[TBL] [Abstract][Full Text] [Related]
27. miR-323a regulates ERBB4 and is involved in depression.
Fiori LM; Kos A; Lin R; Théroux JF; Lopez JP; Kühne C; Eggert C; Holzapfel M; Huettl RE; Mechawar N; Belzung C; Ibrahim EC; Chen A; Turecki G
Mol Psychiatry; 2021 Aug; 26(8):4191-4204. PubMed ID: 33219358
[TBL] [Abstract][Full Text] [Related]
28. Distribution of microRNAs associated with major depressive disorder among blood compartments.
Homorogan C; Enatescu VR; Nitusca D; Marcu A; Seclaman E; Marian C
J Int Med Res; 2021 Apr; 49(4):3000605211006633. PubMed ID: 33827323
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
Wilson C; Li S; Hannan AJ; Renoir T
Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
[TBL] [Abstract][Full Text] [Related]
30. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
Lundin NB; Sepe-Forrest L; Gilbert JR; Carver FW; Furey ML; Zarate CA; Nugent AC
J Affect Disord; 2021 Jan; 279():239-249. PubMed ID: 33074143
[TBL] [Abstract][Full Text] [Related]
31. Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder.
He S; Liu X; Jiang K; Peng D; Hong W; Fang Y; Qian Y; Yu S; Li H
J Psychiatr Res; 2016 Jul; 78():65-71. PubMed ID: 27078210
[TBL] [Abstract][Full Text] [Related]
32. Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
Qu Y; Yang C; Ren Q; Ma M; Dong C; Hashimoto K
Sci Rep; 2017 Nov; 7(1):15725. PubMed ID: 29147024
[TBL] [Abstract][Full Text] [Related]
33. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
34. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.
Lopez JP; Lim R; Cruceanu C; Crapper L; Fasano C; Labonte B; Maussion G; Yang JP; Yerko V; Vigneault E; El Mestikawy S; Mechawar N; Pavlidis P; Turecki G
Nat Med; 2014 Jul; 20(7):764-8. PubMed ID: 24908571
[TBL] [Abstract][Full Text] [Related]
35. Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice.
Higuchi F; Uchida S; Yamagata H; Abe-Higuchi N; Hobara T; Hara K; Kobayashi A; Shintaku T; Itoh Y; Suzuki T; Watanabe Y
J Neurosci; 2016 Jul; 36(27):7253-67. PubMed ID: 27383599
[TBL] [Abstract][Full Text] [Related]
36. P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depression.
Veldman ER; Mamula D; Jiang H; Tiger M; Ekman CJ; Lundberg J; Svenningsson P
J Affect Disord; 2021 Jul; 290():240-244. PubMed ID: 34010748
[TBL] [Abstract][Full Text] [Related]
37. Alterations in microRNA of extracellular vesicles associated with major depression, attention-deficit/hyperactivity and anxiety disorders in adolescents.
Honorato-Mauer J; Xavier G; Ota VK; Chehimi SN; Mafra F; Cuóco C; Ito LT; Ormond R; Asprino PF; Oliveira A; Bugiga AVG; Torrecilhas AC; Bressan R; Manfro GG; Miguel EC; Rohde LA; Pan PM; Salum GA; Pellegrino R; Belangero S; Santoro ML
Transl Psychiatry; 2023 Feb; 13(1):47. PubMed ID: 36746925
[TBL] [Abstract][Full Text] [Related]
38. Peripheral whole blood microRNA alterations in major depression and bipolar disorder.
Maffioletti E; Cattaneo A; Rosso G; Maina G; Maj C; Gennarelli M; Tardito D; Bocchio-Chiavetto L
J Affect Disord; 2016 Aug; 200():250-8. PubMed ID: 27152760
[TBL] [Abstract][Full Text] [Related]
39. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Paoli C; Misztak P; Mazzini G; Musazzi L
Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
[TBL] [Abstract][Full Text] [Related]
40. The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
Melo A; Kokras N; Dalla C; Ferreira C; Ventura-Silva AP; Sousa N; Pêgo JM
Transl Psychiatry; 2015 May; 5(5):e573. PubMed ID: 26080090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
